MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
48 hedge funds and large institutions have $22M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
47% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
48
Holding in Top 10
–
Calls
$160K
Puts
$214K
Top Buyers
| 1 | +$525K | |
| 2 | +$465K | |
| 3 | +$107K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$71K |
| 5 |
AAM
Azzad Asset Management
Falls Church,
Virginia
|
+$36.5K |
Top Sellers
| 1 | -$111K | |
| 2 | -$68.2K | |
| 3 | -$40K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$20.2K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.8K |